Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for treating inflammatory bowel disease

A technology for inflammatory bowel disease and prescriptions, which is applied in the field of combined formulas of Chinese medicinal materials and amino acids, can solve problems such as large side effects and unsatisfactory effects, and achieve good therapeutic effects, prolong human life, and enhance oxygen supply

Inactive Publication Date: 2016-03-30
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] 1. 0.6 grams of Danshen, 0.5 grams of threonine, and 1.2 grams of glutamine are made into chewing agents, 2 to 4 times a day.

[0025] 2. 0.3 grams of Salvia miltiorrhiza, 0.25 grams of threonine, and 0.6 grams of glutamine are made into chewing agents, 2 to 4 times a day.

[0026] 3. 0.6 grams of salvia miltiorrhiza, 0.5 grams of threonine, and 1.2 grams of glutamine are made into medicines, 2 to 4 times a day.

[0027] 4. 0.3 grams of salvia miltiorrhiza, 0.25 grams of threonine, and 0.6 grams of glutamine are made into medicines, 2 to 4 times a day.

[0028] 5. 6 grams of Salvia miltiorrhiza, 0.5 grams of threonine, and 1.2 grams of glutamine are made into oral preparations, 2 to 4 times a day.

[0029] Sixth, 3 grams of Danshen, 0.25 grams of threonine, and 0.6 grams of glutamine are made into oral agents, 2 to 4 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. Intestinal epidermal goblet cells are reinforced to construct a normal intestinal surface mucus layer barrier in order to prevent intestinal antigens from approaching, contacting, adhering and entering intestine wall tissues, so abnormal immune response and inflammation generation are blocked out. Salvia miltiorrhiza has the efficacy of enhancing human body blood supply and oxygen supply; threonine is a composition part of mucoproteins, and is an essential amino acid in human bodies; and glutamine is the main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition obtained through combining Salvia miltiorrhiza, ginseng and glutamine has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective formula for treating the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immune system and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/00A61K31/198
CPCA61K9/0056A61K31/198A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products